Patellofemoral osteoarthritis
Conditions
Brief summary
Change in KOOS-5 subjective score from baseline to the 24-month follow-up
Detailed description
Mean KOOS subscores at all timepoints (baseline, 6, 12 and 24 months), Kujala Anterior Knee Pain Scale at 6, 12 and 24 months, WOMAC Score at baseline, 6, 12 and 24 months, EQ-5D-5L at baseline 6, 12 and 24 months, GROC likert scale at baseline, 6, 12 and 24 months, Marx Activity Rating Scale at baseline, 6, 12 and 24 months, VAS Score at baseline, 6, 12 and 24 months, Patient Satisfaction Questionnaire at 24 months, MRI at baseline, 6, 12 and 24 months, X-ray at baseline, 6, 12 and 24 months, Safety (number of SARs and SUSARs), Number of treatment failures at 24 months
Interventions
DRUGN-TEC
Sponsors
Universitaetsspital Basel
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in KOOS-5 subjective score from baseline to the 24-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean KOOS subscores at all timepoints (baseline, 6, 12 and 24 months), Kujala Anterior Knee Pain Scale at 6, 12 and 24 months, WOMAC Score at baseline, 6, 12 and 24 months, EQ-5D-5L at baseline 6, 12 and 24 months, GROC likert scale at baseline, 6, 12 and 24 months, Marx Activity Rating Scale at baseline, 6, 12 and 24 months, VAS Score at baseline, 6, 12 and 24 months, Patient Satisfaction Questionnaire at 24 months, MRI at baseline, 6, 12 and 24 months, X-ray at baseline, 6, 12 and 24 months, Safety (number of SARs and SUSARs), Number of treatment failures at 24 months | — |
Countries
Austria, Croatia, Germany, Italy, Netherlands, Poland, Sweden
Outcome results
None listed